Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Longitudinal Efficacy Analysis of Patients with Active Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Dmards: Response Following Rescue from Baricitinib 2mg to 4mg Once-Daily Fleischmann, R., Genovese, M. C., Cardoso, A., Sun, L., Chen, Y., Walls, C. D., Schlichting, D. E., Takeuchi, T., Dougados, M., Smolen, J. S., Curtis, J. R. WILEY. 2018
View details for Web of Science ID 000447268901107